Skip to main content
. Author manuscript; available in PMC: 2012 Oct 1.
Published in final edited form as: Leuk Res. 2011 Jul 8;35(10):1402–1408. doi: 10.1016/j.leukres.2011.06.018

Figure 3. Plumbagin exposure leads to increased expression of TRAIL receptors in human chronic myelogenous leukemia cells.

Figure 3

The effect of plumbagin treatment on the expression of The TRAIL receptors, DR4 and DR5 was determined by exposing K562 cells to various concentrations of plumbagin for 24. Trail receptor expression was determined by flow cytometric analysis. The data represent the mean fluorescence intensity (MFI) from a representative experiment which was repeated at least three times with similar results.